Patterns of medication use in the RRI-CKD study: Focus on medications with cardiovasculars effects

Nephrology Dialysis Transplantation

Volumn 20, Issue , 2005, Pages 1110-1115

  Bailie, George R ^a   Eisele, George ^b   Liu, Lei ^c   Roys, Erik ^c   Kiser, Margaret ^d   Finkelstein, Frederick ^e   Wolfe, Robert ^f   Port, Friedrich ^f   Burrows Hudson, Sally ^g   Saran, Rajiv ^f  

^a ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e Metabolism Associates   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

^g Nephrology Management Group Inc   (United States)

Author keywords

Chronic kidney disease; Medication use; Prescription patterns; RRI CKD study

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIANEMIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRON; PHOSPHATE BINDING AGENT; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ANEMIA; ARTICLE; CAUCASIAN; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMOGRAPHY; DIABETES MELLITUS; DISEASE SEVERITY; DRUG UTILIZATION; FEMALE; GLOMERULUS FILTRATION RATE; HEART PROTECTION; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; INFORMATION PROCESSING; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRESCRIPTION; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEINURIA; RACE; SEX; STATISTICAL ANALYSIS; UNITED STATES;

AGED; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; DRUG UTILIZATION; EPOETIN ALFA; GLOMERULAR FILTRATION RATE; HEMATINICS; HUMANS; KIDNEY DISEASES; LOGISTIC MODELS; MIDDLE AGED;

EID: 20844455116     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh771     Document Type: Article

References (20)

1. United States Renal Data System 1998 Annual Data Report. Medication use among dialysis patients in the DMMS. Am J Kidney Dis 1998; 32 [Suppl 1]: S60-S68
2. Manley HJ, McClaran ML, Overbay DK et al. Factors associated with medication-related problems in ambulatory hemodialysis patients. Am J Kidney Dis 2003; 41: 386-393
3. Abramson JL, Jurkovitz CT, Vaccarino V, Weintraub WS, McClellan W. Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC study. Kidney Int 2003; 64: 610-615
4. Kausz AT, Khan SS, Abichandani R et al. Management of patients with chronic renal insufficiency in the northeastern United States. J Am Soc Nephrol 2001; 12: 1501-1507
5. Tonelli M, Bohm C, Pandeya S et al. Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency. Am J Kidney Dis 2001; 37: 484-489
6. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470
7. Perlman RL, Kiser M, Finkelstein F et al. The Longitudinal Chronic Kidney Disease Study: a prospective cohort study of predialysis renal failure. Semin Dial 2003; 16: 418-423
8. Young EW, Goodkin DA, Mapes DL et al. The Dialysis Outcomes and Practice Patterns Study (DOPPS): an international hemodialysis study. Kidney Int 2000; 57 [Suppl 74]: S74-S81
9. Bailie GR, Mason NA, Bragg-Gresham JL, Gillespie BW, Young EW. Analgesic prescription patterns among hemodialysis patients in the DOPPS: potential for underprescription. Kidney Int 2004; 61: 2419-2425
10. Mason NA, Bailie GR, Satayathum S et al. HMG-coenzyme A reductase inhibitor use is associated with mortality reduction in hemodialysis patients. Am J Kidney Dis 2005; 45: 119-126
11. National Kidney Foundation. Kidney Disease Outcomes Quality Initiative Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000. Available at: http://www.kidney.org/professionals/kdoqi/guidelines_updates/ doqi_uptoc.html#an
12. Centers for Medicare and Medicaid Services End Stage Renal Disease Clinical Performance Measures Project 2003 Report. Available at: http://www.cms.hhs.gov/esrd/1.asp#9
13. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J Am Med Assoc 2001; 285: 2486-2497
14. National Kidney Foundation. Kidney Disease Outcomes Quality Initiative Clinical Practice Guidelines for Managing Dyslipidemias in Chronic Kidney Disease. Available at: http://www.kidney.org/professionals/kdoqi/guidelines_lipids/index.htm
15. Parving HH, Hovind P. Microalbuminuria in type 1 and type 2 diabetes mellitus: evidence with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers for treating early and preventing clinical nephropathy. Curr Hypertens Rep 2002; 4: 387-393
16. National Kidney Foundation. Kidney Disease Outcomes Quality Initiative Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease. Available at: http://www.kidney.org/professionals/kdoqi/guidelines_bp/index.htm
17. Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother 2004; 38: 303-312
18. Coresh J, Astor BC, Greene T et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 1-12
19. Kidney Early Evaluation Program Annual Data Report. National Kidney Foundation. Am J Kidney Dis 2003; 42 [Suppl 4]: S1-S60
20. John R, Webb M, Young A, Stevens PE. Unreferred chronic kidney disease: a longitudinal study. Am J Kidney Dis 2004; 43: 825-835